The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change-5.0% to $113.50
Predicted High$121.50at 1 month
Predicted Low$113.50at 6 months
Max Drawdown (predicted)-5.0%
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Aug 1, 2026 12:59 am
Bear
INCY trends lower to
$113.50
(-5.0% from $119.52)
by Feb 2027.
ride-then-fade
ThesisINCY has momentum from a strong Q2 beat and EU Opzelura approval, but the composite fair value sits below current price. Expect near-term drift higher on sentiment tailwind, then gradual mean-reversion toward the $110-115 fair-value band as the catalyst fades and no new earnings print arrives until late in the window.
Invalidated ifA break above $130 on new pipeline data or below $105 on Jakafi erosion news would falsify this path.
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $119.52 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Aug 1, 2026
—
$119.52at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Aug 15, 2026
$110.47–$128.57typical range · internal point $120.80
—
±7.6%
7/10
Post-beat momentum and EU approval buzz persist
What actually happened:
closed $120.17
on Aug 14, 2026 = +0.5% vs the call
(predicted +1.1%)
· direction HIT
(called flat, was flat)
· off by 0.5 pp
· accuracy 10/10
· typical range ±7.6%:
inside the band
· S&P +4.0%
over the same window — beat it
1 month
Sep 1, 2026
$106.40–$132.64typical range · internal point $121.50
—
±11.0%
6/10
Low-beta drift higher in neutral tape
2 months
Oct 1, 2026
$119.00
—
-0.4%
5/10
Catalyst fades, value gravity starts pulling
3 months
Nov 1, 2026
$116.50
—
-2.5%
5/10
Convergence toward signal-adjusted fair value
4 months
Dec 1, 2026
$115.00
—
-3.8%
5/10
No catalysts, mean-reversion continues quietly
5 months
Jan 1, 2027
$114.00
—
-4.6%
4/10
Year-end tax positioning on winners
6 months
Feb 1, 2027
$113.50
—
-5.0%
4/10
Settles near fair-value band pre-Q4 print
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$117.45
(-1.7%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.